Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $777.57 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $174.51 | 9 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $134.49 | 7 | $0 (2021) |
| ABBVIE INC. | $97.23 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $87.22 | 5 | $0 (2024) |
| PFIZER INC. | $69.42 | 5 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $48.10 | 3 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $41.62 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $34.57 | 3 | $0 (2021) |
| Mylan Specialty L.P. | $28.76 | 2 | $0 (2024) |
| Gilead Sciences, Inc. | $26.26 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.35 | 4 | ABBVIE INC. ($44.87) |
| 2023 | $34.68 | 2 | Novartis Pharmaceuticals Corporation ($19.56) |
| 2021 | $124.84 | 8 | AbbVie Inc. ($52.36) |
| 2020 | $111.14 | 5 | Janssen Pharmaceuticals, Inc ($67.24) |
| 2019 | $131.68 | 9 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($47.97) |
| 2018 | $216.41 | 13 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($104.31) |
| 2017 | $74.47 | 4 | Valeant Pharmaceuticals North America LLC ($41.62) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/29/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: COVID-19 | ||||||
| 08/10/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/12/2021 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/05/2021 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/30/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: COVID-19 | ||||||
| 06/03/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.62 | General |
| Category: Cardiovascular | ||||||
| 04/22/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2021 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/05/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/02/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/01/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/12/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/12/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/11/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.67 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/26/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/15/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 687 | 1,206 | $245,664 | $86,956 |
| 2022 | 10 | 794 | 1,407 | $208,082 | $86,674 |
| 2021 | 9 | 746 | 1,445 | $196,654 | $83,245 |
| 2020 | 9 | 828 | 1,674 | $222,482 | $97,248 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 253 | 637 | $100,517 | $38,139 | 37.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 105 | 187 | $43,824 | $16,798 | 38.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 163 | 173 | $45,735 | $14,794 | 32.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 54 | 54 | $23,462 | $6,973 | 29.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 39 | $11,875 | $3,786 | 31.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 34 | 77 | $7,323 | $2,896 | 39.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 12 | $7,645 | $1,973 | 25.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 27 | 27 | $5,283 | $1,597 | 30.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 281 | 684 | $87,552 | $36,348 | 41.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 127 | 207 | $38,088 | $16,117 | 42.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 152 | 156 | $28,704 | $12,224 | 42.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 45 | $15,615 | $6,497 | 41.6% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 42 | 75 | $10,800 | $4,063 | 37.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 38 | 129 | $9,159 | $3,817 | 41.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 62 | 64 | $8,128 | $3,167 | 39.0% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $4,480 | $2,039 | 45.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $3,540 | $1,550 | 43.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 16 | 16 | $2,016 | $852.84 | 42.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 280 | 772 | $98,816 | $41,638 | 42.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 155 | 159 | $29,256 | $12,757 | 43.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 86 | 134 | $24,656 | $10,568 | 42.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 56 | 202 | $14,342 | $5,873 | 40.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 72 | 72 | $9,144 | $3,856 | 42.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 22 | $7,634 | $3,328 | 43.6% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 35 | 44 | $6,336 | $2,378 | 37.5% |
About Dr. Steffan Libarnes, M.D
Dr. Steffan Libarnes, M.D is a Hospitalist healthcare provider based in Saint Joseph, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2009. The National Provider Identifier (NPI) number assigned to this provider is 1326376773.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steffan Libarnes, M.D has received a total of $777.57 in payments from pharmaceutical and medical device companies, with $84.35 received in 2024. These payments were reported across 45 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($777.57).
As a Medicare-enrolled provider, Libarnes has provided services to 3,055 Medicare beneficiaries, totaling 5,732 services with total Medicare billing of $354,123. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Hospitalist
- Location Saint Joseph, MO
- Active Since 11/23/2009
- Last Updated 10/09/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1326376773
Products in Payments
- RELISTOR (Drug) $135.75
- XARELTO (Drug) $134.49
- ELIQUIS (Drug) $103.99
- ENTRESTO (Drug) $87.22
- XIFAXAN (Drug) $80.38
- TEFLARO (Drug) $52.36
- DIFICID (Drug) $48.10
- DALVANCE (Drug) $44.87
- Veklury (Drug) $26.26
- LifeVest (Device) $21.67
- YUPELRI (Drug) $16.62
- SPIRIVA RESPIMAT (Drug) $13.72
- Perforomist (Drug) $12.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Saint Joseph
Allison Roe, D.o, D.O
Hospitalist — Payments: $1,062
Michael Wang, Md, MD
Hospitalist — Payments: $632.14
Nafis Islam, Md, MD
Hospitalist — Payments: $616.46
Daniel Bosis, M.d, M.D
Hospitalist — Payments: $381.62
Aadil Ahmed, Do, DO
Hospitalist — Payments: $365.53
Dr. Amulya Dakka, Md, MD
Hospitalist — Payments: $292.64